Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2015-10-08 03:54 2015-10-05 RMD RESMED INC Douglas Robert Andrew Officer OPT+S $52.13 6,333 $330,139 54,839
2015-10-07 20:12 2015-10-06 SYK STRYKER CORP STRYKER RONDA E Director SELL $95.35 12,000 $1,144,247 8,952,233
2015-10-08 03:55 2015-10-05 RMD RESMED INC PENDARVIS DAVID Officer OPT+S $52.47 5,500 $288,563 77,180
2015-10-08 02:57 2015-10-06 DXCM DEXCOM INC Balo Andrew K Officer SELL $82.29 8,216 $676,083 117,695
2015-10-06 19:02 2015-10-05 SYK STRYKER CORP STRYKER RONDA E Director SELL $96.88 6,000 $581,283 8,964,233
2015-10-07 00:44 2015-10-06 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, 10% owner SELL $106.17 10,000 $1,061,656 400,716
2015-10-05 23:10 2015-10-05 BSX BOSTON SCIENTIFIC CORP Pratt Timothy A. Officer SELL $17.34 3,500 $60,690 319,393
2015-10-06 02:47 2015-10-05 ICUI ICU MEDICAL INC/DE SAUCEDO JOSEPH R Director SELL $107.72 1,875 $201,967 1,556
2015-10-06 03:27 2015-10-01 RMD RESMED INC FARRELL PETER C Director, Officer OPT+S $50.93 27,169 $1,383,636 289,826
2015-10-06 00:01 2015-10-01 CTSO Cytosorbents Corp Kraus Al Director OPT+S $6.26 10,000 $62,591 55,746
2015-10-06 00:25 2015-10-05 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, 10% owner SELL $107.44 10,000 $1,074,380 400,716
2015-10-02 23:21 2015-10-01 BSX BOSTON SCIENTIFIC CORP Pratt Timothy A. Officer OPT+S $16.33 17,000 $277,663 322,893
2015-10-02 21:41 2015-10-02 SYK STRYKER CORP STRYKER RONDA E Director SELL $95.36 6,000 $572,144 8,970,233
2015-10-01 19:33 2015-09-30 SYK STRYKER CORP STRYKER RONDA E Director SELL $93.88 12,000 $1,126,586 8,976,233
2015-09-29 19:22 2015-09-28 SYK STRYKER CORP STRYKER RONDA E Director SELL $93.95 12,000 $1,127,448 8,988,233
2015-09-29 23:12 2015-09-25 LMAT LEMAITRE VASCULAR INC Gebauer Peter R Officer OPT+S $13.91 5,441 $75,658 70,420
2015-09-28 17:08 2015-09-24 CTSO Cytosorbents Corp Kraus Al Director OPT+S $6.44 10,000 $64,361 55,746
2015-09-25 22:12 2015-09-24 SYK STRYKER CORP STRYKER RONDA E Director SELL $98.41 12,000 $1,180,884 9,000,233
2015-09-26 00:05 2015-09-23 DXCM DEXCOM INC DOUBLEDAY RICHARD Officer SELL $97.00 4,217 $409,061 23,403
2015-09-26 00:04 2015-09-23 DXCM DEXCOM INC Pacelli Steven Robert Officer OPT+S $98.08 14,000 $1,373,154 216,214
2015-09-23 21:40 2015-09-22 SYK STRYKER CORP STRYKER RONDA E Director SELL $98.38 12,000 $1,180,614 9,012,233
2015-09-22 23:30 2015-09-18 LMAT LEMAITRE VASCULAR INC LeMaitre George W Director, Officer, 10% owner SELL $14.37 46,391 $666,857 112,031
2015-09-23 02:54 2015-09-21 DXCM DEXCOM INC Balo Andrew K Officer SELL $100.72 7,859 $791,570 125,911
2015-09-22 01:35 2015-09-18 HART Harvard Apparatus Regenerative Technology, Inc. LaFrancesca Saverio Officer BUY $1.29 9,500 $12,210 33,998
2015-09-21 21:00 2015-09-18 SYK STRYKER CORP STRYKER RONDA E Director SELL $100.01 12,000 $1,200,126 9,024,233
2015-09-22 02:10 2015-09-17 CTSO Cytosorbents Corp Kraus Al Director OPT+S $6.64 10,000 $66,373 55,746
2015-09-22 01:15 2015-09-18 DXCM DEXCOM INC ROPER JESS Officer OPT+S $101.22 7,000 $708,534 99,424
2015-09-19 01:51 2015-08-28 HART Harvard Apparatus Regenerative Technology, Inc. LaFrancesca Saverio Officer BUY $0.96 2,500 $2,400 24,498
2015-09-18 03:35 2015-09-15 RMD RESMED INC Hollingshead James Officer SELL $50.67 4,455 $225,717 67,680
2015-09-18 03:34 2015-09-15 RMD RESMED INC Farrell Michael J. Officer OPT+S $50.89 5,975 $304,068 172,370
2015-09-17 15:32 2015-09-15 CRY Artivion Inc. Benson James Director SELL $9.65 5,839 $56,346 70,352
2015-09-17 22:08 2015-09-16 SYK STRYKER CORP STRYKER RONDA E Director SELL $100.24 12,000 $1,202,882 9,036,233
2015-09-18 00:50 2015-09-15 LMAT LEMAITRE VASCULAR INC LeMaitre George W Director, Officer, 10% owner SELL $13.96 49,559 $691,670 113,971
2015-09-18 01:18 2015-09-15 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer OPT+S $96.22 29,999 $2,886,399 346,064
2015-09-16 22:58 2015-09-14 TNDM TANDEM DIABETES CARE INC Sheridan John F Officer OPT+S $12.51 2,000 $25,020 4,084
2015-09-17 00:02 2015-09-15 HAE HAEMONETICS CORP CONCANNON BRIAN Director, Officer OPT+S $35.15 6,569 $230,900 147,040
2015-09-16 01:00 2015-09-14 PDEX PRO DEX INC Swenson Nicholas John Director BUY $2.30 22,537 $51,835 47,588
2015-09-15 23:34 2015-09-11 CRY Artivion Inc. Benson James Director SELL $9.65 4,161 $40,154 76,191
2015-09-15 18:17 2015-09-14 SYK STRYKER CORP STRYKER RONDA E Director SELL $99.03 12,000 $1,188,316 9,048,233
2015-09-14 23:41 2015-09-11 CRY Artivion Inc. Benson James Director SELL $9.65 3,359 $32,414 76,993
2015-09-14 15:29 2015-09-10 AMDA Sintx Technologies, Inc. LOMBARDI TY Officer BUY $0.40 25,000 $10,000 51,971
2015-09-14 16:00 2015-09-10 SYK STRYKER CORP STRYKER RONDA E Director SELL $98.37 12,000 $1,180,481 9,060,233
2015-09-15 00:39 2015-09-10 CTSO Cytosorbents Corp Kraus Al Director OPT+S $7.26 10,000 $72,600 55,746
2015-09-15 02:44 2015-09-11 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer OPT+S $96.50 47,500 $4,583,698 459,018
2015-09-12 03:00 2015-09-09 DXCM DEXCOM INC LORD JONATHAN T MD Director SELL $90.96 10,000 $909,602 131,582
2015-09-12 02:08 2015-09-09 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer OPT+S $95.91 62,501 $5,994,446 459,018
2015-09-10 00:03 2015-09-04 BONE Xtant Medical Holdings, Inc. DEEDRICK JOHN ARTHUR Director BUY $3.68 6,793 $24,998 16,621
2015-09-09 15:47 2015-09-04 BONE Xtant Medical Holdings, Inc. LOPACH MICHAEL A Director BUY $3.68 10,869 $39,998 14,258
2015-09-09 15:44 2015-09-04 BONE Xtant Medical Holdings, Inc. WICKWIRE JON M. Director BUY $3.68 10,869 $39,998 31,247
2015-09-09 15:42 2015-09-04 BONE Xtant Medical Holdings, Inc. Goldberger Daniel S Director, Officer BUY $3.68 81,522 $300,001 81,522
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.